Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Yuriko Shimizu"'
Autor:
Kohei Mori, Kazumasa Matsumoto, Masaomi Ikeda, Dai Koguchi, Yuriko Shimizu, Hideyasu Tsumura, Daisuke Ishii, Shoutaro Tsuji, Yuichi Sato, Masatsugu Iwamura
Publikováno v:
Diagnostics, Vol 13, Iss 19, p 3067 (2023)
Objective: To investigate the correlation between total protein expression of heart development protein with EGF-like domain 1 (HEG1) and clinicopathological characteristics in patients with bladder cancer (BC) after radical cystectomy (RC). Patients
Externí odkaz:
https://doaj.org/article/fe157ca2c90a469083cdd52f2e592da9
Autor:
Shigenobu Kanba, Mitsukuni Murasaki, Tsukasa Koyama, Masahiro Takeuchi, Yuriko Shimizu, Eri Arita, Kentaro Kuroishi, Shinya Kamei
Publikováno v:
BMC Psychiatry, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background In an 8-week, randomized, placebo-controlled, double-blind study, an extended-release formulation of quetiapine, quetiapine XR, demonstrated efficacy and safety in Japanese patients with bipolar depression. Bipolar disorder is a c
Externí odkaz:
https://doaj.org/article/2572161ce5ee46518df94a47506796f6
Autor:
Dai Koguchi, Kazumasa Matsumoto, Masaomi Ikeda, Yuriko Shimizu, Marie Nakamura, Yutaka Shiono, Hiroki Katsumata, Yuichi Sato, Masatsugu Iwamura
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 20; Pages: 12119
An investigation of alternatives to immune checkpoint inhibitors for advanced urothelial cancer (aUC), with biologic information, is urgently needed. Clinical data for 53 patients who received gemcitabine–paclitaxel therapy (GP) as 2nd-line chemoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2d17c7a56fca5bdc50686573e89423b
Autor:
Dai Koguchi, Kazumasa Matsumoto, Yuriko Shimizu, Noriyuki Amano, Soichiro Shimura, Masaomi Ikeda, Hideyasu Tsumura, Ken Ichi Tabata, Yuichi Sato, Masatsugu Iwamura
Publikováno v:
Journal of Urology. 207
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29e58a3ceb73d8672a1a0facc357e228
https://doi.org/10.1097/ju.0000000000002515.11
https://doi.org/10.1097/ju.0000000000002515.11
Autor:
Kohei Mori, Kazumasa Matsumoto, Noriyuki Amano, Dai Koguchi, Soichiro Shimura, Masahiro Hagiwara, Yuriko Shimizu, Masaomi Ikeda, Yuichi Sato, Masatsugu Iwamura
Publikováno v:
Cancers; Volume 14; Issue 6; Pages: 1576
Objective: To investigate the relationship between clinicopathological findings and membranous CD155 (mCD155) or cytoplasmic CD155 (cCD155) expression in bladder cancer (BC). Methods: We retrospectively analyzed 103 patients with BC who underwent rad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3635cdf7b3ce61356b8e088ea22e6e7f
Autor:
Mayuko Nishi, Masatsugu Iwamura, Yuichi Sato, Noriyuki Amano, Masaomi Ikeda, Kazumasa Matsumoto, Ryo Nagashio, Megumi Nomura, Akihide Ryo, Yuriko Shimizu
Publikováno v:
Cancer Biomarkers. 24:91-96
BACKGROUND New biomarkers may help us provide individualized prognosis and allow risk-stratified clinical decision making about radical treatment. OBJECTIVES This study aimed to determine the tumor necrosis factor of receptor superfamily 19 (TROY) ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d89bbe0e82a7d8b3e67757ac9502e06
https://doi.org/10.3233/cbm-181911
https://doi.org/10.3233/cbm-181911
Autor:
Shuhei Hirano, Masatsugu Iwamura, Yuriko Shimizu, Kazumasa Matsumoto, Dai Koguchi, Masaomi Ikeda, Yuichi Sato, Momoko Kobayashi
Publikováno v:
Cancers
Volume 13
Issue 8
Cancers, Vol 13, Iss 1748, p 1748 (2021)
Volume 13
Issue 8
Cancers, Vol 13, Iss 1748, p 1748 (2021)
Simple Summary Unfavorable results following radical cystectomy for bladder cancer (BCa) highlights a critical need for a novel prognostic molecular biomarker with potential therapeutic benefits. In the present study, the expression levels of AHNAK2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69b6f578f4059da0974ab39aebddbad7
https://pubmed.ncbi.nlm.nih.gov/33918555
https://pubmed.ncbi.nlm.nih.gov/33918555
Autor:
Noriyuki Amano, Masatsugu Iwamura, Kazumasa Matsumoto, Yuichi Sato, Daisuke Ishii, Marie Nakamura, Yuriko Shimizu, Hideyasu Tsumura
Publikováno v:
Urologic oncology. 39(3)
Objective We sought to identify heterogeneous nuclear ribonucleoprotein A3 (HNRNPA3) expression in bladder cancer and its relationship to clinicopathological findings and prognosis. Methods Immunohistochemical staining for HNRNPA3 was performed on 12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bdd0b045c3fb4fce5a930e6fefc3bd09
https://pubmed.ncbi.nlm.nih.gov/33160845
https://pubmed.ncbi.nlm.nih.gov/33160845
Autor:
Takahiro Hirayama, Yasukiyo Murakami, Yuriko Shimizu, Wataru Ishikawa, Masatsugu Iwamura, Kazumasa Matsumoto
Publikováno v:
Cancer biomarkers : section A of Disease markers. 28(1)
BACKGROUND No study has yet investigated the use of electronic nose (eNose) technology to reveal pattern recognition of urological diseases, including bladder cancer. OBJECTIVE We sought to determine the diagnostic performance of the eNose in recogni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ebfdf573607c6d7bb859d3b4cad173b
https://pubmed.ncbi.nlm.nih.gov/32176623
https://pubmed.ncbi.nlm.nih.gov/32176623
Autor:
Shuhei Hirano, Kazumasa Matsumoto, Kohei Mochizuki, Masatsugu Iwamura, Yuichi Sato, Soichiro Shimura, Masaomi Ikeda, Yuriko Shimizu, Dai Koguchi, Yutaka Shiono
Publikováno v:
Cancers, Vol 13, Iss 5150, p 5150 (2021)
Cancers
Volume 13
Issue 20
Cancers
Volume 13
Issue 20
Tumor markers that can be detected at an early stage are needed. Here, we evaluated the epiplakin expression levels in sera from patients with bladder cancer (BC). Using a micro-dot blot array, we evaluated epiplakin expression levels in 60 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3ac7c9129a377c287dd31822b8a863d
https://doi.org/10.3390/cancers13205150
https://doi.org/10.3390/cancers13205150